2022 Webinar: Covid in Focus: Outpatient Therapeutics and Managing Liver Transplant Donors and Recipients-Covid in Focus: Outpatient Therapeutics and Managing Liver Transplant Donors and Recipients

Video Transcription

Video Summary

The AASLD webinar titled "COVID in Focus: Outpatient Therapeutics and Managing Liver Transplant Donors and Recipients" focused on the clinical questions and challenges faced when managing liver transplant patients during the COVID-19 pandemic. The webinar featured presentations from experts in the field who discussed topics such as outpatient therapeutics, the use of COVID-positive donors, and the management of COVID-positive recipients. In terms of outpatient therapeutics, monoclonal antibodies were highlighted as a useful treatment option, particularly for high-risk patients. However, the efficacy of these antibodies may be limited by the evolution of the virus. Antiviral agents were also discussed, with Paxil-Ovid identified as a highly effective option, although there are concerns about drug interactions, particularly for transplant patients. The webinar also addressed the use of COVID-positive donors in liver transplantation. While there can be concerns about viral particles in the blood and tissue of these donors, evidence suggests that the risk of transmission is low, particularly for non-lung recipients. The webinar noted that using COVID-positive donors could help address the shortage of organs and potentially save lives. The panelists emphasized the importance of balancing the risk of COVID-19 transmission with the risk of mortality on the waitlist, and highlighted the need for further research on the long-term outcomes of transplant recipients who receive COVID-positive donors. Overall, the webinar provided valuable insights into the current landscape and challenges of managing liver transplant patients during the COVID-19 pandemic.

Keywords

AASLD webinar

COVID in Focus

Outpatient Therapeutics

Managing Liver Transplant Donors

Managing Liver Transplant Recipients

Monoclonal Antibodies

Antiviral Agents

Paxil-Ovid

COVID-positive Donors

Transplantation during COVID-19